← Leaderboards
Lubbertus C Mulder
Aaron Diamond Aids Research Center
$5,902,087
Attributed
$5,902,087
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $722.5K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,902,087 · 6
By mechanism
R61$2,167,425 · 1
R21$1,939,979 · 4
R01$1,794,683 · 1
Top collaborators
No co-investigators on record.
Most similar at Aaron Diamond Aids Research Center
Same institution · by research overlap
- Paul D Bieniasz$36,585,539
- Theodora Hatziioannou$13,024,728
Others in their field
Top investigators on “Hiv-1”
- Barton F Haynes · Duke University$476,288,740
- Lawrence Corey · Fred Hutchinson Cancer Center$445,419,385
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$294,186,693
- Constance Ann Benson · University Of California, San Diego$272,046,180
- Peter B. Gilbert · Fred Hutchinson Cancer Center$173,010,936
- Dan H. Barouch · Fred Hutchinson Cancer Center$166,542,502
Research focus
Hiv-1InfectionReportingInsightCellsAffectMolecularProteinsEndogenous RetrovirusesHuman GenomeBaseVirusHiv InfectionsGenerationsRetroviridaeDeep SequencingCell TypeCd4 Positive T LymphocytesComplexResolutionPredispositionProvirusesLife Cycle StagesShapes
Grant awards (19)
HERV proteogenomics of narcotic-driven HIV latency$722,475
R61 · FY2025 · DA · contact PI
HERV proteogenomics of narcotic-driven HIV latency$722,475
R61 · FY2024 · DA · contact PI
HERV proteogenomics of narcotic-driven HIV latency$722,475
R61 · FY2023 · DA · contact PI
HIV-1-dependent HERV-K proteome$211,875
R21 · FY2021 · AI · contact PI
HIV-1-dependent HERV-K proteome$271,625
R21 · FY2020 · AI · contact PI
Impact of HERV-K expression on HIV-1 life cycle$322,050
R01 · FY2018 · GM · contact PI
Impact of HERV-K expression on HIV-1 life cycle$322,050
R01 · FY2017 · GM · contact PI
Impact of HERV-K expression on HIV-1 life cycle$322,050
R01 · FY2016 · GM · contact PI
Impact of HERV-K expression on HIV-1 life cycle$103,920
R01 · FY2016 · GM · contact PI
Impact of HERV-K expression on HIV-1 life cycle$375,726
R01 · FY2015 · GM · contact PI
Impact of HERV-K expression on HIV-1 life cycle$26,837
R01 · FY2015 · GM · contact PI
Impact of HERV-K expression on HIV-1 life cycle$322,050
R01 · FY2014 · GM · contact PI
Genome stability function of APOBEC3 retroviral restriction factors$211,875
R21 · FY2012 · AI · contact PI
Genome stability function of APOBEC3 retroviral restriction factors$254,250
R21 · FY2011 · AI · contact PI
Genome stability maintenance factors in early HIV-1 infection$15,255
R21 · FY2009 · AI · contact PI
Genome stability maintenance factors in early HIV-1 infection$207,849
R21 · FY2008 · AI · contact PI
Genome stability maintenance factors in early HIV-1 infection$254,250
R21 · FY2007 · AI · contact PI
Host factors impact in early phases of HIV-1 infection$256,500
R21 · FY2005 · AI
Host factors impact in early phases of HIV-1 infection$256,500
R21 · FY2004 · AI